AusPAR: Dolutegravir/Lamivudine

Australian Public Assessment Report

AusPAR

AusPAR: Product Dolutegravir/Lamivudine [PDF, 766.85 KB]

AusPAR: Product Dolutegravir/Lamivudine [Word, 1.41 MB]

Attachment: Product Dolutegravir/Lamivudine [PDF, 227.86 KB]

Attachment: Product Dolutegravir/Lamivudine [Word, 117.12 KB]

Device/Product Name

Dovato

Active ingredients

Dolutegravir/Lamivudine

AusPAR Date

4 December 2019

Published

24 December 2019

Submission Number

PM-2018-04002-1-2

Submission Type

New combination of previously approved active ingredients

Decision

Approved